322 related articles for article (PubMed ID: 12787070)
1. Functional consequences of homo- but not hetero-oligomerization between transporters for the biogenic amine neurotransmitters.
Kocabas AM; Rudnick G; Kilic F
J Neurochem; 2003 Jun; 85(6):1513-20. PubMed ID: 12787070
[TBL] [Abstract][Full Text] [Related]
2. Functional coupling of serotonin and noradrenaline transporters.
Horschitz S; Hummerich R; Schloss P
J Neurochem; 2003 Aug; 86(4):958-65. PubMed ID: 12887693
[TBL] [Abstract][Full Text] [Related]
3. Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux.
Wall SC; Gu H; Rudnick G
Mol Pharmacol; 1995 Mar; 47(3):544-50. PubMed ID: 7700252
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type.
Eshleman AJ; Carmolli M; Cumbay M; Martens CR; Neve KA; Janowsky A
J Pharmacol Exp Ther; 1999 May; 289(2):877-85. PubMed ID: 10215666
[TBL] [Abstract][Full Text] [Related]
5. Permeation and gating residues in serotonin transporter.
Chen JG; Rudnick G
Proc Natl Acad Sci U S A; 2000 Feb; 97(3):1044-9. PubMed ID: 10655481
[TBL] [Abstract][Full Text] [Related]
6. Molecular cloning and characterization of an L-epinephrine transporter from sympathetic ganglia of the bullfrog, Rana catesbiana.
Apparsundaram S; Moore KR; Malone MD; Hartzell HC; Blakely RD
J Neurosci; 1997 Apr; 17(8):2691-702. PubMed ID: 9092590
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of metaiodobenzylguanidine uptake by the norepinephrine, dopamine and serotonin transporters.
Glowniak JV; Kilty JE; Amara SG; Hoffman BJ; Turner FE
J Nucl Med; 1993 Jul; 34(7):1140-6. PubMed ID: 8315492
[TBL] [Abstract][Full Text] [Related]
8. Biosynthesis, N-glycosylation, and surface trafficking of biogenic amine transporter proteins.
Ramamoorthy S; Melikian HE; Qian Y; Blakely RD
Methods Enzymol; 1998; 296():347-70. PubMed ID: 9779460
[No Abstract] [Full Text] [Related]
9. Tails of serotonin and norepinephrine transporters: deletions and chimeras retain function.
Blakely RD; Moore KR; Qian Y
Soc Gen Physiol Ser; 1993; 48():283-300. PubMed ID: 8503051
[No Abstract] [Full Text] [Related]
10. A mutation in the human norepinephrine transporter gene (SLC6A2) associated with orthostatic intolerance disrupts surface expression of mutant and wild-type transporters.
Hahn MK; Robertson D; Blakely RD
J Neurosci; 2003 Jun; 23(11):4470-8. PubMed ID: 12805287
[TBL] [Abstract][Full Text] [Related]
11. Structural determinants of neurotransmitter transport using cross-species chimeras: studies on serotonin transporter.
Barker EL; Blakely RD
Methods Enzymol; 1998; 296():475-98. PubMed ID: 9779469
[No Abstract] [Full Text] [Related]
12. Cell-specific sorting of biogenic amine transporters expressed in epithelial cells.
Gu HH; Ahn J; Caplan MJ; Blakely RD; Levey AI; Rudnick G
J Biol Chem; 1996 Jul; 271(30):18100-6. PubMed ID: 8663573
[TBL] [Abstract][Full Text] [Related]
13. Placental biogenic amine transporters: cloning and expression.
Padbury JF; Tseng YT; McGonnigal B; Penado K; Stephan M; Rudnick G
Brain Res Mol Brain Res; 1997 Apr; 45(1):163-8. PubMed ID: 9105686
[TBL] [Abstract][Full Text] [Related]
14. An analysis of the binding of cocaine analogues to the monoamine transporters using tensor decomposition 3-d QSAR.
Appell M; Dunn WJ; Reith ME; Miller L; Flippen-Anderson JL
Bioorg Med Chem; 2002 May; 10(5):1197-206. PubMed ID: 11886784
[TBL] [Abstract][Full Text] [Related]
15. Cocaine and antidepressant-sensitive biogenic amine transporters exist in regulated complexes with protein phosphatase 2A.
Bauman AL; Apparsundaram S; Ramamoorthy S; Wadzinski BE; Vaughan RA; Blakely RD
J Neurosci; 2000 Oct; 20(20):7571-8. PubMed ID: 11027216
[TBL] [Abstract][Full Text] [Related]
16. Stable expression of biogenic amine transporters reveals differences in inhibitor sensitivity, kinetics, and ion dependence.
Gu H; Wall SC; Rudnick G
J Biol Chem; 1994 Mar; 269(10):7124-30. PubMed ID: 8125921
[TBL] [Abstract][Full Text] [Related]
17. Interaction of cis-(6-benzhydrylpiperidin-3-yl)benzylamine analogues with monoamine transporters: structure-activity relationship study of structurally constrained 3,6-disubstituted piperidine analogues of (2,2-diphenylethyl)-[1-(4-fluorobenzyl)piperidin-4-ylmethyl]amine.
Kolhatkar RB; Ghorai SK; George C; Reith ME; Dutta AK
J Med Chem; 2003 May; 46(11):2205-15. PubMed ID: 12747792
[TBL] [Abstract][Full Text] [Related]
18. Physiological genomics of antidepressant targets: keeping the periphery in mind.
Blakely RD
J Neurosci; 2001 Nov; 21(21):8319-23. PubMed ID: 11606618
[TBL] [Abstract][Full Text] [Related]
19. Transporter-mediated actions of R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane.
Shimazu S; Tsunekawa H; Yoneda F; Katsuki H; Akaike A; Janowsky A
Eur J Pharmacol; 2003 Dec; 482(1-3):9-16. PubMed ID: 14659999
[TBL] [Abstract][Full Text] [Related]
20. Cocaine mechanisms: enhanced cocaine, fluoxetine and nisoxetine place preferences following monoamine transporter deletions.
Hall FS; Li XF; Sora I; Xu F; Caron M; Lesch KP; Murphy DL; Uhl GR
Neuroscience; 2002; 115(1):153-61. PubMed ID: 12401330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
